artenimol has been researched along with Alveolitis, Fibrosing in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Dou, H; Guo, T; Jiang, K; Jiang, X; You, X; Zhang, C; Zhao, X; Zhu, X | 1 |
| Ge, XP; Li, JM; Lv, CJ; Qiu, J; Xu, Y; Yang, DX; Yu, Y; Yuan, WD; Zhang, HQ; Zhou, DL; Zhou, HH; Zhu, MZ | 1 |
| Fu, Q; Li, N; Liu, T; Lv, C; Qiu, X; Sun, Y; Wang, L; Yang, D; Yuan, W | 1 |
3 other study(ies) available for artenimol and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2/STAT3 signaling.
Topics: Animals; Artemisinins; Janus Kinase 2; Male; Pneumonia; Pulmonary Fibrosis; Rats; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor | 2022 |
Dihydroartemisinin alleviates oxidative stress in bleomycin-induced pulmonary fibrosis.
Topics: Actins; Alveolar Epithelial Cells; Animals; Antimetabolites, Antineoplastic; Antioxidants; Artemisinins; Bleomycin; Cadherins; Lung; Male; Myofibroblasts; NF-E2-Related Factor 2; Oxidative Stress; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley | 2018 |
Dihydroartemisinin supresses inflammation and fibrosis in bleomycine-induced pulmonary fibrosis in rats.
Topics: Actins; Animals; Artemisinins; Bleomycin; Fibrosis; Inflammation; Male; NF-kappa B; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2015 |